MedPath

Endocrine Research Society

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Necessity for Lipid Lowering Therapy in Type 2 Diabetes Patients

Completed
Conditions
Type 2 Diabetes
Interventions
Other: Stop lipid lowering therapy (statin)
First Posted Date
2008-03-19
Last Posted Date
2011-07-22
Lead Sponsor
Endocrine Research Society
Target Recruit Count
25
Registration Number
NCT00639080
Locations
🇨🇦

Endocrine Research Society, Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath